Angelo Porreca1, Katie Palmer2, Walter Artibani3, Alessandro Antonelli4, Lorenzo Bianchi5, Eugenio Brunocilla5,6, Aldo Massimo Bocciardi7, Maurizio Brausi8, Gian Maria Busetto9, Marco Carini10,11, Giuseppe Carrieri12, Antonio Celia13, Luca Cindolo14, Giovanni Cochetti15, Renzo Colombo16, Ettore De Berardinis9, Ottavio De Cobelli17,18, Fabrizio Di Maida10, Amelio Ercolino5, Franco Gaboardi19, Antonio Galfano8, Andrea Gallina16, Michele Gallucci9, Carlo Introini20, Ettore Mearini15, Andrea Minervini10, Francesco Montorsi16, Gennaro Musi17, Giovannalberto Pini19, Riccardo Schiavina5,6, Silvia Secco7, Sergio Serni10,11, Claudio Simeone21, Giovanni Tasso10, Daniele D'Agostino3. 1. Istituto Oncologico Veneto IRCCS, Padova, Italy. 2. Department of Internal Medicine and Geriatrics, Università Cattolica del Sacro Cuore, Largo Francesco Vito, 1, 00168, 00136, Rome, Italy. katie.palmer@ki.se. 3. Department of Urology, Policlinico Abano Terme, Abano Terme, PD, Italy. 4. Department of Urology, Azienda Ospedaliera Universitaria Integrata (A.O.U.I.), Verona, Italy. 5. Department of Urology, University of Bologna, Bologna, Italy. 6. Division of Urology, IRCCS Azienda Ospedaliero-Universitaria di Bologna, Bologna, Italy. 7. Struttura Complessa Urologia, ASST, Grande Ospedale Metropolitano Niguarda, Milan, Italy. 8. Divisione Urologia AUSL, Modena, Italy. 9. Department of Maternal-Child and Urological Sciences, Sapienza Rome University, Policlinico Umberto I Hospital, Rome, Italy. 10. Department of Urology, Careggi Hospital, University of Florence, Florence, Italy. 11. Unit of Oncologic Minimally-Invasive Urology and Andrology, Careggi Hospital, Florence, Italy. 12. Urology and Renal Transplantation Unit, Department of Medical and Surgical Sciences, University of Foggia, Foggia, Italy. 13. Department of Urology, San Bassiano Hospital, Bassano Del Grappa, Italy. 14. Department of Urology, "Villa Stuart" Private Hospital, Rome, Italy. 15. Department of Urology, University of Perugia, Perugia, Italy. 16. Department of Urology and Division of Experimental Oncology, URI, Urological Research Institute, IRCCS San Raffaele Scientific Institute, Milan, Italy. 17. IEO European Institute of Oncology, IRCCS, Milan, Italy. 18. Department of Hematology and Hemato-Oncology, Universty of Milan, Milan, Italy. 19. Department of Urology, San Raffaele Turro Hospital, Milano, Italy. 20. Department of Urology, E.O. Ospedali Galliera, Genova, Italy. 21. Department of Urology, University of Brescia, Brescia, Italy.
Abstract
BACKGROUND: Bladder cancer is the ninth most common type of cancer worldwide. In the past, radical cystectomy via open surgery has been considered the gold-standard treatment for muscle invasive bladder cancer. However, in recent years there has been a progressive increase in the use of robot-assisted laparoscopic radical cystectomy. The aim of the current project is to investigate the surgical, oncological, and functional outcomes of patients with bladder cancer who undergo radical cystectomy comparing three different surgical techniques (robotic-assisted, laparoscopic, and open surgery). Pre-, peri- and post-operative factors will be examined, and participants will be followed for a period of up to 24 months to identify risks of mortality, oncological outcomes, hospital readmission, sexual performance, and continence. METHODS: We describe a protocol for an observational, prospective, multicenter, cohort study to assess patients affected by bladder neoplasms undergoing radical cystectomy and urinary diversion. The Italian Radical Cystectomy Registry is an electronic registry to prospectively collect the data of patients undergoing radical cystectomy conducted with any technique (open, laparoscopic, robotic-assisted). Twenty-eight urology departments across Italy will provide data for the study, with the recruitment phase between 1st January 2017-31st October 2020. Information is collected from the patients at the moment of surgical intervention and during follow-up (3, 6, 12, and 24 months after radical cystectomy). Peri-operative variables include surgery time, type of urinary diversion, conversion to open surgery, bleeding, nerve sparing and lymphadenectomy. Follow-up data collection includes histological information (e.g., post-op staging, grading, and tumor histology), short- and long-term outcomes (e.g., mortality, post-op complications, hospital readmission, sexual potency, continence etc). DISCUSSION: The current protocol aims to contribute additional data to the field concerning the short- and long-term outcomes of three different radical cystectomy surgical techniques for patients with bladder cancer, including open, laparoscopic, and robot-assisted. This is a comparative-effectiveness trial that takes into account a complex range of factors and decision making by both physicians and patients that affect their choice of surgical technique. TRIAL REGISTRATION: ClinicalTrials.gov , NCT04228198 . Registered 14th January 2020- Retrospectively registered.
BACKGROUND:Bladder cancer is the ninth most common type of cancer worldwide. In the past, radical cystectomy via open surgery has been considered the gold-standard treatment for muscle invasive bladder cancer. However, in recent years there has been a progressive increase in the use of robot-assisted laparoscopic radical cystectomy. The aim of the current project is to investigate the surgical, oncological, and functional outcomes of patients with bladder cancer who undergo radical cystectomy comparing three different surgical techniques (robotic-assisted, laparoscopic, and open surgery). Pre-, peri- and post-operative factors will be examined, and participants will be followed for a period of up to 24 months to identify risks of mortality, oncological outcomes, hospital readmission, sexual performance, and continence. METHODS: We describe a protocol for an observational, prospective, multicenter, cohort study to assess patients affected by bladder neoplasms undergoing radical cystectomy and urinary diversion. The Italian Radical Cystectomy Registry is an electronic registry to prospectively collect the data of patients undergoing radical cystectomy conducted with any technique (open, laparoscopic, robotic-assisted). Twenty-eight urology departments across Italy will provide data for the study, with the recruitment phase between 1st January 2017-31st October 2020. Information is collected from the patients at the moment of surgical intervention and during follow-up (3, 6, 12, and 24 months after radical cystectomy). Peri-operative variables include surgery time, type of urinary diversion, conversion to open surgery, bleeding, nerve sparing and lymphadenectomy. Follow-up data collection includes histological information (e.g., post-op staging, grading, and tumor histology), short- and long-term outcomes (e.g., mortality, post-op complications, hospital readmission, sexual potency, continence etc). DISCUSSION: The current protocol aims to contribute additional data to the field concerning the short- and long-term outcomes of three different radical cystectomy surgical techniques for patients with bladder cancer, including open, laparoscopic, and robot-assisted. This is a comparative-effectiveness trial that takes into account a complex range of factors and decision making by both physicians and patients that affect their choice of surgical technique. TRIAL REGISTRATION: ClinicalTrials.gov , NCT04228198 . Registered 14th January 2020- Retrospectively registered.
Authors: Marko Babjuk; Andreas Böhle; Maximilian Burger; Otakar Capoun; Daniel Cohen; Eva M Compérat; Virginia Hernández; Eero Kaasinen; Joan Palou; Morgan Rouprêt; Bas W G van Rhijn; Shahrokh F Shariat; Viktor Soukup; Richard J Sylvester; Richard Zigeuner Journal: Eur Urol Date: 2016-06-17 Impact factor: 20.096
Authors: Daniele Romagnoli; Federico Mineo Bianchi; Paolo Corsi; Daniele D'Agostino; Marco Giampaoli; Lorenzo Bianchi; Francesco Chessa; Riccardo Schiavina; Eugenio Brunocilla; Walter Artibani; Angelo Porreca Journal: Surg Technol Int Date: 2019-05-15
Authors: Günter Niegisch; Alessandro Nini; René Michalski; Alina Henn; David Mally; Peter Albers; Robert Rabenalt Journal: Urol Int Date: 2018-07-25 Impact factor: 2.089
Authors: Gian Maria Busetto; Daniele D'Agostino; Michele Colicchia; Katie Palmer; Walter Artibani; Alessandro Antonelli; Lorenzo Bianchi; Aldo Bocciardi; Eugenio Brunocilla; Marco Carini; Giuseppe Carrieri; Luigi Cormio; Ugo Giovanni Falagario; Ettore De Berardinis; Alessandro Sciarra; Costantino Leonardo; Francesco Del Giudice; Martina Maggi; Ottavio de Cobelli; Matteo Ferro; Gennaro Musi; Amelio Ercolino; Fabrizio Di Maida; Andrea Gallina; Carlo Introini; Ettore Mearini; Giovanni Cochetti; Andrea Minervini; Francesco Montorsi; Riccardo Schiavina; Sergio Serni; Claudio Simeone; Paolo Parma; Armando Serao; Mario Salvatore Mangano; Giorgio Pomara; Pasquale Ditonno; Alchiede Simonato; Daniele Romagnoli; Alessandro Crestani; Angelo Porreca Journal: Front Oncol Date: 2022-05-05 Impact factor: 5.738
Authors: Angelo Porreca; Luca Di Gianfrancesco; Walter Artibani; Gian Maria Busetto; Giuseppe Carrieri; Alessandro Antonelli; Lorenzo Bianchi; Eugenio Brunocilla; Aldo Massimo Bocciardi; Marco Carini; Antonio Celia; Giovanni Cochetti; Andrea Gallina; Ettore Mearini; Andrea Minervini; Riccardo Schiavina; Sergio Serni; Daniele D'Agostino; Erica Debbi; Paolo Corsi; Alessandro Crestani Journal: Cent European J Urol Date: 2022-05-04